Low prevalence of anti-annexin V antibodies in anti-phospholipid syndrome accompanied by spontaneous abortion;Faible prevalence des anticorps anti-annexine V dans le syndrome des antiphospholipides avec pertes foetales

Revue de Medecine Interne

Volumn 20, Issue 9, 1999, Pages 762-765

  Siaka, C ^a   Lambert, M ^b   Caron, C ^a   Amiral, J ^c   Hachulla, E ^b   Hatron, P Y ^b   Goudemand, J ^a  

^a Service d'Hématologie B   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c NONE

Author keywords

Anti annexin V antibodies; Anti phospholipid syndrome; Repetitive fetal loss

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LIPOCORTIN 5; LUPUS ANTICOAGULANT; AUTOANTIBODY; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS WASTAGE; HUMAN; PATHOGENESIS; PLACENTA; PROTEIN ANALYSIS; RISK ASSESSMENT; SPONTANEOUS ABORTION; THROMBOSIS; ADOLESCENT; ADULT; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANNEXIN A5; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 0033191572     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)88682-8     Document Type: Article

References (18)

1. 1 Krikun G, Lockwood CJ, Wu XX, Zhou XD, Guller S, Calandri C, et al. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 1994; 15 : 601-12.
2. 2 Rand JH, Wu XX, Guller S, Gil J, Guha A, Scher J, et al. Reduction of annexin V (placental anticoagulant protein I) on placental villi of women with antiphospholipid antibodies and reccurrent spontaneous abortions. Am J Obstet Gynecol 1994; 171 : 1566-72.
3. 3 Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, et al. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N Engl J Med 1997; 337 : 154-60.
4. 4 Galli M, Bevers EM. Inhibition of phospholipid-dependent coagulation reactions by antiphospholipid antibodies: possible modes of action. Lupus 1994; 3 : 223-8.
5. 5 Caruso A, De Carolis S, Ferrazani S, Valesini G, Caforio L, Mancuso S. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 1993; 82 : 970-7.
6. 6 Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73 : 541-5.
7. 7 Carreras LO, Defreyn G, Machin SJ, Vermylen J, Deman R, Spitz B, et al. Arterial thrombosis, intrauterine death and "lupus" anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; i : 244-6.
8. 8 Lin YL, Wang CT. Activation of human platelets by the rabbit anticardiolipin antibodies. Blood 1992; 80 : 3135-43.
9. 9 Cariou R, Tobelem G, Bellucci S, Soria J, Soria C, Maclouf J, et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells. Inhibition of thrombomodulin dependent protein C activation. Thromb Haemostas 1988; 60 : 54-8.
10. 10 Branch DW, Rodgers GM. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am J Obstet Gynecol 1993; 168 : 206-10.
11. 11 Sammaritano LR, Gharavi AE. Antiphospholipid antibodies and placental anticoagulant protein I. Lupus 1994; 3 : 263-5.
12. 12 Andree HA, Stuart MC, Hermens WT, Reutelingsperger CP, Hemker HC, Frederik PM. Clustering of lipid-bound annexin V may explains its anticoagulant effects. J Biol Chem 1992; 267 : 17907-12.
13. 13 Katano K, Aoki K, Sasa H, Ogasawara M, Matsuura E, Yagami Y. β2-glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996; 11 : 509-12.
14. 14 Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO. Relationship of antiβ2-glycoprotein I and antiprothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 1997; 78 : 1008-14.
15. 15 Gris JC, Brun S, Maugard C, Berlan J, Neveu S, Mares P, et al. Prevalence of subgroups of antiphospholipid antibodies in recurrent primary early miscarriages [abstract]. Thromb Haemost 1997; 170 Suppl : 170.
16. 16 Matsuda J, Gotoh M, Saitoh N, Gohchi K, Tsukamoto M, et Yamamoto T. Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia. Thromb Res 1994; 75 : 105-6.
17. 17 Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and /or anticardiolipin antibody. Am J Haematol 1994; 47 : 56-8.
18. 18 Rand J, Wu XX, Andree HA, Ross JB, Rusinova E, Gascon-Lema MG, et al. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood 1998; 92 : 1652-60.